Australia markets open in 9 hours 4 minutes

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8000+0.0570 (+7.67%)
At close: 04:00PM EDT
0.7732 -0.03 (-3.35%)
After hours: 06:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.43M
Enterprise value 20.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.85
Price/book (mrq)5.82
Enterprise value/revenue 5.40
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-30.43%
S&P500 52-week change 322.55%
52-week high 32.0000
52-week low 30.6470
50-day moving average 31.0057
200-day moving average 31.1624

Share statistics

Avg vol (3-month) 3166.52k
Avg vol (10-day) 3215.61k
Shares outstanding 527.84M
Implied shares outstanding 627.84M
Float 821.2M
% held by insiders 111.38%
% held by institutions 124.21%
Shares short (14 June 2024) 4186.05k
Short ratio (14 June 2024) 41.27
Short % of float (14 June 2024) 40.70%
Short % of shares outstanding (14 June 2024) 40.67%
Shares short (prior month 15 May 2024) 4259.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 301 Apr 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-209.55%

Management effectiveness

Return on assets (ttm)-128.49%
Return on equity (ttm)-272.79%

Income statement

Revenue (ttm)3.73M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)195.40%
Gross profit (ttm)N/A
EBITDA -12.71M
Net income avi to common (ttm)-12.8M
Diluted EPS (ttm)-0.5800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.43M
Total cash per share (mrq)0.09
Total debt (mrq)121.9k
Total debt/equity (mrq)3.16%
Current ratio (mrq)3.06
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-11.83M
Levered free cash flow (ttm)-7.44M